Patent directory · USPTO A61K / A61P
Patents matching “United States Government as represented by the Department of Veterans Affairs”
144 pharma patents match "United States Government as represented by the Department of Veterans Affairs" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 144 pharmaceutical patents matching "United States Government as represented by the Department of Veterans Affairs" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12397066
Delivery of gene therapy treatments
granted -
US 12398123
Chemical inhibition of the E3 ligase subunit FBXO7 confers neuroprotection and anti-inflammatory activity by stabilizing mitochondria
granted -
US 12383500
Nanoliposome compositions and methods of using the same
granted -
US 12385010
Gene therapy for recessive dystrophic epidermolysis bullosa using genetically corrected autologous keratinocytes
granted -
US 12377135
GHRH antagonists for use in a method of treating sarcoidosis
granted -
US 12357615
Compositions for the treatment of brain tumors
granted -
US 12350274
Nucleotide analogs
granted -
US 12351625
Therapeutic antibodies against osteopontin
granted -
US 12336974
Methods and compositions for preventing and treating auditory dysfunctions
granted -
US 12331105
Broadly neutralizing antibodies against HIV
granted -
US 12274723
Bacteriophage compositions and methods for treatment of bacterial infections
granted -
US 12269803
Krüppel-like factor 15 (KLF15) small molecule agonists in kidney disease
granted -
US 12246012
Method for treating nervous system injuries using boldine and derivatives thereof
granted -
US 12227479
Dihydropyridines for the treatment of cognitive impairment or traumatic brain injury
granted -
US 12226423
Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or pharmaceutically acceptable salt thereof and at least one cyclic oligosaccharide
granted -
US 12215108
Development of potential antidotes for arsenicals
granted -
US 12178626
Encapsulated gas or partial vacuum CT contrast material
granted -
US 12173314
Gene therapy for recessive dystrophic epidermolysis bullosa using genetically corrected autologous keratinocytes
granted -
US 12161655
Methods of treating mycobacterial infections using tetracycline compounds
granted -
US 12150777
Treatment of depression
granted -
US 12121526
Targeting NCCA-ATP channel for organ protection following ischemic episode
granted -
US 12122853
Compositions and methods of inhibiting the binding of plasma IGG autoantibodies to serotonin 2A receptor
granted -
US 12116416
Targeting intracellular target-binding determinants with intracellular antibodies
granted -
US 12110504
Gene therapy for recessive dystrophic epidermolysis bullosa using genetically corrected autologous keratinocytes
granted